BiotechTube
Home/Repertoire Immune Medicines/John Delyani, PhD, MBA
JD

John Delyani, PhD, MBA

Chief Business Officer

Repertoire Immune Medicines

Therapeutic Areas

OncologyAutoimmune Diseases

Repertoire Immune Medicines Pipeline

DrugIndicationPhase
Cancer TherapeuticsSolid and Hematological CancersClinical
Tolerizing TherapiesAutoimmune DiseasesClinical

Leadership Team at Repertoire Immune Medicines

TS
Torben Straight Nissen, PhD
Chief Executive Officer
AC
Anthony Coyle, PhD
President, Research and Development
RA
Robert Andtbacka, MD, CM, FACS, FRCSC
Chief Medical Officer
View full Repertoire Immune Medicines profile